Foundry Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Foundry Partners's AMGN Position: Q3 2020 in Review
Foundry Partners sold out of Amgen (AMGN) in Q3 2020, closing a stake of 65,248 shares — an estimated $15.4M sold.
Foundry Partners first reported a position in AMGN in Q4 2013 and held it in 20 quarters. The position peaked at $19.7M in Q1 2018. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.
- Foundry Partners reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
- Foundry Partners sold 65,248 Amgen shares in Q3 2020, an estimated $15.4M.
- Foundry Partners first reported a position in Amgen in Q4 2013 and held it in 20 quarters.
- Foundry Partners's Amgen position peaked at $19.7M in Q1 2018.
- 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.
Based on Foundry Partners's 13F filing for Q3 2020, filed 23 Oct 2020.